Nerivio® Drug-free Wearable Surpasses 100,000 Migraine Treatments in the US
Similar Posts
FDA Approves Theranica’s Nerivio® for Acute Treatment of Migraine in Adolescents
The Prescribed Wearable Device is Now indicated for Patients 12 Years Old and Above Theranica, a prescribed digital therapeutics (PDT)…
Clearlake Capital-Backed nThrive Announces Name Change to FinThrive as Part of a Forthcoming Rebrand
New Company vision challenges the traditional approach from legacy incumbent solutions to revenue cycle management software and technology…
Rush University Medical Center Expands Deployment
of Nuance Dragon Ambient eXperience (DAX) to
14 Clinical SpecialtiesLeading academic health center aims to improve the care experience and reduce physician burnout after a successful pilot found…
Henry Schein Marks 25 Years of ‘Holiday Cheer For Children’ Program
For Two and A Half Decades, Team Schein Has Helped Spread Joy to Communities Around the World Henry…
Blue Shield of California Expands Collaboration with Dignity Health Hospitals to Make Billing and Payment Easier for Patients, Providers
Innovative program expands to 26 facilities throughout California to better support providers during COVID-19 Blue Shield of California announced the…
AccessHope Announces Collaboration with UT Southwestern Medical Center to Expand Cancer Expertise Access in Southern States
● UT Southwestern Harold C. Simmons Comprehensive Cancer Center is the seventh National Cancer Institute-Designated Comprehensive Cancer Center…
